NAGE
What one share of Niagen Bioscience holds
Medicinal Chemicals and Botanical Products
On May 21, 2008, Cody Resources, Inc., a Nevada corporation and a public company, (Cody) entered into an Agreement and Plan of Merger (Merger Agreement), by and among Cody, CDI Acquisition, Inc., a California corporation and wholly-owned subsidiary of Cody (Acquisition Sub), and ChromaDex, Inc.
Niagen Bioscience’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $1.52 |
|---|---|
| Profit | $0.19 |
| Cash and investments | $0.85 |
| Book value | $1.05 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2010 | $0.47 | −$0.12 | $0.01 | −$0.18 | — | $0.24 |
| 2011 | $0.32 | −$0.36 | $0.01 | −$0.17 | — | $0.11 |
| 2012 | $0.36 | −$0.39 | $0.00 | −$0.32 | — | $0.13 |
| 2013 | $0.30 | −$0.12 | $0.00 | −$0.12 | — | $0.16 |
| 2014 | $0.43 | −$0.15 | $0.00 | −$0.08 | — | $0.11 |
| 2015 | $0.50 | −$0.08 | $0.01 | −$0.07 | — | $0.15 |
| 2016 | $0.58 | −$0.08 | $0.04 | −$0.12 | — | $0.27 |
| 2017 | $0.48 | −$0.26 | $0.03 | −$0.25 | — | $0.98 |
| 2018 | $0.57 | −$0.61 | $0.02 | −$0.40 | — | $0.49 |
| 2019 | $0.81 | −$0.56 | $0.01 | −$0.37 | — | $0.34 |
| 2020 | $0.97 | −$0.33 | — | −$0.17 | — | $0.27 |
| 2021 | $1.00 | −$0.40 | — | −$0.36 | — | $0.47 |
| 2022 | $1.03 | −$0.24 | — | −$0.22 | — | $0.38 |
| 2023 | $1.11 | −$0.07 | — | $0.09 | — | $0.38 |
| 2024 | $1.27 | $0.11 | — | $0.15 | — | $0.60 |
| 2025 | $1.51 | $0.20 | — | $0.16 | — | $0.96 |